RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation
Clinical trial NCT01317615 · COMPLETED
Trial details
- NCT number
- NCT01317615
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2015-03-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.